Sort
25,944 grants matching “neurodegeneration”
Molecular phenotyping of cortical cell types in multiple rodent models of ALS
$370,781Eric F Schmidt · Rockefeller University · R01 · FY2018 · NS
Cellular mechanisms of dietary therapy for epilepsy
$370,781Gary I Yellen · Harvard Medical School · R01 · FY2016 · NS
PS1 mediates the neuroprotective functions of the ephrinB/EphB system
$370,781Nikolaos Robakis · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · NS
Microglial gene regulation and phagocytosis in prodromal Alzheimer's Disease
$370,778Martin R Schiller · University Of Nevada Las Vegas · P20 · FY2020 · GM
Statistical methods for population-level cell-type-specific analyses of tissue omics data for Alzheimer's disease
$370,759Jiebiao Wang · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AG
Autophagy and dietary restriction mechanisms in the C. elegans model of aging
$370,734Malene Hansen · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · AG
Cellular and Molecular Consequences of Respiratory Chain Defects in Neurons
$370,690Carlos Torres Moraes · University Of Miami School Of Medicine · R01 · FY2023 · NS
Cellular and Molecular Consequences of Respiratory Chain Defects in Neurons
$370,690Carlos Torres Moraes · University Of Miami School Of Medicine · R01 · FY2022 · NS
METABOTROPIC GLUTAMATE RECEPTORS IN NEURODEGENERATION
$370,667Massachusetts General Hospital · R37 · FY2000 · AG
Genipinâs ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia
$370,623Nadja Zeltner · University Of Georgia · R01 · FY2025 · NS
Targeting Inflammasome with stable endocannabinoid ligand AMG315. CRISPR/Cas9 and nanotechnology study in the context of HIV and cannabinoid
$370,610Madhavan P Nair · Florida International University · R01 · FY2023 · DA
Neuroimaging and clinical Endpoints With High-dimensional analysis Of Pathological Endophenotypes in TBI (NEW-HOPE-TBI)
$370,609Christopher D Keene · University Of Washington · U01 · FY2025 · NS
Cellular mechanisms of dietary therapy for epilepsy
$370,599Gary I Yellen · Harvard Medical School · R01 · FY2013 · NS
Mechanism of Neuropathy Target Esterase/swisscheese
$370,561Moses Victor Chao · New York University School Of Medicine · R01 · FY2007 · NS
Mechanism of Neuropathy Target Esterase/swisscheese
$370,561Moses Victor Chao · New York University School Of Medicine · R01 · FY2009 · NS
Mechanism of Neuropathy Target Esterase/swisscheese
$370,561Moses Victor Chao · New York University School Of Medicine · R01 · FY2008 · NS
Genomic, physiological, and environmental predictors of AD risk, resilience and resistance
$370,535Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2020 · AG
Genomic, physiological, and environmental predictors of AD risk, resilience and resistance
$370,535Lindsay A. Farrer · Boston University Medical Campus · U19 · FY2024 · AG
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
$370,515Kathleen E. Rodgers · University Of Arizona · P01 · FY2022 · AG
The Role of Adenosine in Retinal Ischemia
$370,500Steven Roth · University Of Chicago · R01 · FY2013 · EY
Gut stress-induced intercellular signaling networks promoting longevity and proteostasis
$370,490Patricija Van Oosten-Hawle · University Of North Carolina Charlotte · R01 · FY2024 · AG
Novel chaperones and neurodegeneration
$370,478Kenneth Matthew Scaglione · Duke University · R01 · FY2020 · NS
TAK1 signaling pathways
$370,462Jun Ninomiya-Tsuji · North Carolina State University Raleigh · R35 · FY2022 · GM
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation
$370,369Yuri Persidsky · Temple Univ Of The Commonwealth · R37 · FY2017 · AA
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activation
$370,369Yuri Persidsky · Temple Univ Of The Commonwealth · R37 · FY2018 · AA